As we get older, we slowly lose the ability to reproduce these natural CBD inhibitors, hence why Full Spectrum CBD products can potentially help in replacing what is lost naturally.
If you have tried CBD products from places like Amazon, they are more than likely CBD Isolate only. Hence why those CBD products did not work. Our Full Spectrum CBD products include 220+ Compounds that are missing from CBD Isolated Products. Those compounds are what your body understands already. Some of the functions of those critical compounds are listed below.
If these functions are not addressed by CBD Isolate products – how could you expect them to work in the first place?
It’s a great question and frankly, the Isolate only manufacturers and retailers are counting on you to not know about these facts.
Full Spectrum CBD is what works. Full Spectrum CBD contains the 220+ compounds that your body is looking for.
As the days go by you’ll hear more and more neat sounding names and hear incredible “marketing” stories from other companies. It’s just that “stories and marketing”. Even the FDA has issued many warning letters demonstrating that own tests found that some products did not contain the amount of CBD they claimed to contain and more.
In humans, the plasma concentration of certain endocannabinoids
In humans, the plasma concentration of certain endocannabinoids (i.e., anandamide) have been found to rise during physical activity; since endocannabinoids can effectively penetrate the blood–brain barrier, it has been suggested that anandamide, along with other euphoriant neurochemicals, contributes to the development of exercise-induced euphoria in humans, a state colloquially referred to as a runner’s high
Two primary endocannabinoid receptors have been identified: CB1, first cloned in 1990; and CB2, cloned in 1993.
CB1 receptors are found predominantly in the brain and nervous system, as well as in peripheral organs and tissues, and are the main molecular target of the endocannabinoid ligand (binding molecule), anandamide, as well as its mimetic phytocannabinoid, THC. One other main endocannabinoid is 2-arachidonoylglycerol (2-AG) which is active at both cannabinoid receptors, along with its own mimetic phytocannabinoid, CBD. 2-AG and CBD are involved in the regulation of appetite, immune system functions and pain management.
Endocannabinoids in plants
The endocannabinoid system is by molecular phylogenetic distribution of apparently ancient lipids in the plant kingdom, indicative of biosynthetic plasticity and potential physiological roles of endocannabinoid-like lipids in plants, and detection of arachidonic acid (AA) indicates chemotaxonomic connections between monophyletic groups with common ancestor dates to around 500 million years ago (silurian; devonian). The phylogenetic distribution of these lipids may be a consequence of interactions/adaptations to the surrounding conditions such as chemical plant-pollinator interactions, communication and defense mechanisms. The two novel EC-like molecules derived from the eicosatetraenoic acid juniperonic acid, an omega-3 structural isomer of AA, namely juniperoyl ethanolamide and 2-juniperoyl glycerol (1/2-AG) in gymnosperms, lycophytes and few monilophytes, show AA is an evolutionarily conserved signalling molecule that acts in plants in response to stress similar to that in animal systems.
As we get older
we slowly lose the ability to reproduce these natural inhibitors, hence why proper cbd products (with the needed compounds) help in replacing what is lost naturally.